PortalPublikationenZeitfaktor und Zeit-Dosis-Verschreibung in der Strahlenthera...

Zeitfaktor und Zeit-Dosis-Verschreibung in der Strahlentherapie von Kopf-Hals-Tumoren

Standard

Zeitfaktor und Zeit-Dosis-Verschreibung in der Strahlentherapie von Kopf-Hals-Tumoren. / Dubben, H H.

in: STRAHLENTHER ONKOL, Jahrgang 170, Nr. 2, 01.02.1994, S. 101-2.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Dubben, HH 1994, 'Zeitfaktor und Zeit-Dosis-Verschreibung in der Strahlentherapie von Kopf-Hals-Tumoren', STRAHLENTHER ONKOL, Jg. 170, Nr. 2, S. 101-2.

APA

Dubben, H. H. (1994). Zeitfaktor und Zeit-Dosis-Verschreibung in der Strahlentherapie von Kopf-Hals-Tumoren. STRAHLENTHER ONKOL, 170(2), 101-2.

Vancouver

Dubben HH. Zeitfaktor und Zeit-Dosis-Verschreibung in der Strahlentherapie von Kopf-Hals-Tumoren. STRAHLENTHER ONKOL. 1994 Feb 1;170(2):101-2.

Bibtex

@article{29ce0396f2b64330968531a22b72ab9c,
title = "Zeitfaktor und Zeit-Dosis-Verschreibung in der Strahlentherapie von Kopf-Hals-Tumoren",
abstract = "BACKGROUND: Clinical data on head and neck tumors presented by Withers et al. are reexamined. Recently it was argued that the relationship between TCD50 and treatment time might be influenced by the practice of prescription.METHOD: In a computer simulation the impact of treatment outcome on the time factor is investigated. For this the genuine local tumor control rates were replaced by either tumor failure rate or by random numbers.RESULTS: The time factor is independent from local tumor control rates in all simulations.CONCLUSIONS: The increase of TCD50 with treatment time reflects solely dose-time prescription habits. The data provide no significant evidence either for an impact of treatment duration or for repopulation during radiotherapy in head and neck tumors.",
keywords = "Computer Simulation, Head and Neck Neoplasms, Humans, Radiotherapy Dosage, Time Factors",
author = "Dubben, {H H}",
year = "1994",
month = feb,
day = "1",
language = "Deutsch",
volume = "170",
pages = "101--2",
journal = "STRAHLENTHER ONKOL",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "2",

}

RIS

TY - JOUR

T1 - Zeitfaktor und Zeit-Dosis-Verschreibung in der Strahlentherapie von Kopf-Hals-Tumoren

AU - Dubben, H H

PY - 1994/2/1

Y1 - 1994/2/1

N2 - BACKGROUND: Clinical data on head and neck tumors presented by Withers et al. are reexamined. Recently it was argued that the relationship between TCD50 and treatment time might be influenced by the practice of prescription.METHOD: In a computer simulation the impact of treatment outcome on the time factor is investigated. For this the genuine local tumor control rates were replaced by either tumor failure rate or by random numbers.RESULTS: The time factor is independent from local tumor control rates in all simulations.CONCLUSIONS: The increase of TCD50 with treatment time reflects solely dose-time prescription habits. The data provide no significant evidence either for an impact of treatment duration or for repopulation during radiotherapy in head and neck tumors.

AB - BACKGROUND: Clinical data on head and neck tumors presented by Withers et al. are reexamined. Recently it was argued that the relationship between TCD50 and treatment time might be influenced by the practice of prescription.METHOD: In a computer simulation the impact of treatment outcome on the time factor is investigated. For this the genuine local tumor control rates were replaced by either tumor failure rate or by random numbers.RESULTS: The time factor is independent from local tumor control rates in all simulations.CONCLUSIONS: The increase of TCD50 with treatment time reflects solely dose-time prescription habits. The data provide no significant evidence either for an impact of treatment duration or for repopulation during radiotherapy in head and neck tumors.

KW - Computer Simulation

KW - Head and Neck Neoplasms

KW - Humans

KW - Radiotherapy Dosage

KW - Time Factors

M3 - SCORING: Zeitschriftenaufsatz

C2 - 8108774

VL - 170

SP - 101

EP - 102

JO - STRAHLENTHER ONKOL

JF - STRAHLENTHER ONKOL

SN - 0179-7158

IS - 2

ER -